Gonorrhea, once straightforward to treat, is becoming harder to manage as the bacteria develop resistance to commonly used antibiotics.
Gonorrhea is a sexually transmitted infection caused by bacteria that can infect the genitals, rectum, and throat. Many people have no symptoms, which is why it can spread without being noticed. When symptoms do appear, they may include discharge, pain during urination, or lower abdominal discomfort. The growing concern is antibiotic resistance. Recent data from Ethiopia shows very high resistance to older drugs like penicillin and tetracycline, and rising resistance to others that were once reliable. This means treatment is becoming more limited and requires careful selection of effective medicines.
Resistance develops when bacteria are repeatedly exposed to antibiotics, especially when treatments are not well targeted or not completed properly. In settings where treatment is based on symptoms rather than lab testing, patients may receive a combination of antibiotics to cover multiple possible infections. While this approach helps ensure immediate care, it can also increase pressure on bacteria to adapt. A common misunderstanding is that gonorrhea is always easy to cure or not serious. In reality, untreated or resistant infections can lead to complications such as pelvic inflammatory disease, infertility, and a higher risk of acquiring or transmitting HIV. Data from abroad shows how quickly the situation can shift. A 2025 study in Hanoi, Vietnam, found that resistance to ceftriaxone has already reached 27 percent, linked to genetic changes that stop the drug from working effectively. Reports from the United Kingdom in the same year also described a rise in resistant cases connected to international travel, showing how quickly these strains can move across borders.
Effective treatment is still available, especially when care is sought early. Current guidelines rely on specific injectable antibiotics that remain effective in most cases. If there is discharge, burning during urination, pelvic pain, or exposure to a partner with an infection, getting tested and treated promptly is important. Even without symptoms, regular screening is recommended for sexually active individuals. Completing treatment exactly as prescribed and ensuring partners are treated at the same time helps prevent reinfection and further spread.
The shift toward resistant infections is a reminder that prevention matters. Consistent condom use, routine testing, and timely treatment reduce risk significantly. Paying attention to sexual health and acting on reliable information supports long-term well-being and helps limit the spread of harder-to-treat infections.
English
Amharic